Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Teva Pharmaceutical aims for $5B in innovative drug revenue by 2030, seeking high margins and cash flow.
Teva Pharmaceutical targets $5B in revenue from innovative medicines by 2030, aiming for a 30% operating margin and over $3.5B in free cash flow.
Mutual Funds' ownership in NSE-listed companies hit a record 10%.
UnitedHealth, Coinbase, and Salesforce were highlighted as stocks to watch, with UnitedHealth's shares up $6.42.
Google launched direct online sales of its hardware in India, and Best Buy's shares fell after Q1 earnings missed expectations.
13 Articles
Teva Pharmaceutical tiene como objetivo $ 5B en ingresos de medicamentos innovadores para el año 2030, buscando altos márgenes y flujo de efectivo.